Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;73(5):545-547.
doi: 10.1016/j.annemergmed.2019.03.015.

Adventures With Andexanet Alfa in Efficacy, Effectiveness, and One-Armed Studies: May 2019 Annals of Emergency Medicine Journal Club

Ryan P Radecki  1 , Rory J Spiegel  2
Affiliations

Adventures With Andexanet Alfa in Efficacy, Effectiveness, and One-Armed Studies: May 2019 Annals of Emergency Medicine Journal Club

Ryan P Radecki et al. Ann Emerg Med. 2019 May.

Abstract

You are reading the 70th installment of Annals of Emergency Medicine Journal Club. As the Journal Club enters its second decade of publication, the format has been revised and will focus on a monthly succinct review of high-impact articles from this journal and other premier medical journals relevant to emergency medicine. The reviews are followed by questions demonstrating principles by which readers—be they clinicians, academics, residents, or medical students—may critically appraise the literature. We are interested in receiving feedback about this feature. Please e-mail journalclub@acep.org with your comments.

PubMed Disclaimer

Comment in

  • Andexanet Response.
    Milling TJ Jr, Connolly S. Milling TJ Jr, et al. Ann Emerg Med. 2019 Nov;74(5):724-725. doi: 10.1016/j.annemergmed.2019.05.033. Ann Emerg Med. 2019. PMID: 31668247 Free PMC article. No abstract available.
  • FDA Approval of Andexanet Alfa Based on a Single-Arm Trial: If There Is a Villain, Who Is It?
    Pallin DJ. Pallin DJ. Ann Emerg Med. 2019 Nov;74(5):725-727. doi: 10.1016/j.annemergmed.2019.05.034. Ann Emerg Med. 2019. PMID: 31668248 No abstract available.
  • In reply.
    Radecki RP, Spiegel RJ, Wang HE. Radecki RP, et al. Ann Emerg Med. 2019 Nov;74(5):727. doi: 10.1016/j.annemergmed.2019.05.035. Ann Emerg Med. 2019. PMID: 31668250 No abstract available.

References

    1. Andexxa: an antidote for apixaban and rivaroxaban. Med Lett Drugs Ther. 2018;60:99–100. - PubMed
    1. Frontera JA, Lewin JJ III, Rabinstein AA, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine. Neurocrit Care. 2016;24:6–46. - PubMed
    1. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191–2194. - PubMed
    1. Siegal DM, Curnutte JT, Connolly SJ, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015;373: 2413–2424. - PubMed
    1. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ. 2003;327:1459–1461. - PMC - PubMed